Published in ASN Neuro on March 03, 2015
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (2005) 74.55
MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (2005) 29.65
New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst (1990) 23.46
Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol (1993) 7.63
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol (2002) 4.50
Selective CD4+ lymphopenia in melanoma patients treated with temozolomide: a toxicity with therapeutic implications. J Clin Oncol (2004) 4.06
Clinical trial substantiates the predictive value of O-6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide. Clin Cancer Res (2004) 3.47
Temozolomide and treatment of malignant glioma. Clin Cancer Res (2000) 2.95
Malignant glioma: lessons from genomics, mouse models, and stem cells. Cell (2012) 2.85
Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression. J Neurooncol (2007) 2.85
Mammalian abasic site base excision repair. Identification of the reaction sequence and rate-determining steps. J Biol Chem (1998) 2.49
Early necrosis following concurrent Temodar and radiotherapy in patients with glioblastoma. J Neurooncol (2006) 2.33
Gold(III) complexes as potential antitumor agents: solution chemistry and cytotoxic properties of some selected gold(III) compounds. J Med Chem (2000) 1.87
Serum transaminase elevations as indicators of hepatic injury following the administration of drugs. Regul Toxicol Pharmacol (1998) 1.58
Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One (2012) 1.18
Chemosensitivity of glioma cells in vitro: a meta analysis. J Cancer Res Clin Oncol (1999) 1.14
Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells. Brain (2013) 1.12
Evaluation of tests used to screen patients with liver disorders. Prim Care (1996) 1.05
Reversing the Warburg effect as a treatment for glioblastoma. J Biol Chem (2013) 1.02
Temozolomide: a milestone in neuro-oncology and beyond? Expert Rev Anticancer Ther (2006) 1.02
Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood-brain tumor barrier. ACS Nano (2013) 1.02
Nuclear permeable ruthenium(II) β-carboline complexes induce autophagy to antagonize mitochondrial-mediated apoptosis. J Med Chem (2010) 1.02
Phenanthroline derivatives with improved selectivity as DNA-targeting anticancer or antimicrobial drugs. ChemMedChem (2008) 1.01
Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation. Radiat Oncol (2011) 1.00
The path for metal complexes to a DNA target. Chem Commun (Camb) (2013) 1.00
Metal-based inhibition of poly(ADP-ribose) polymerase--the guardian angel of DNA. J Med Chem (2011) 0.97
Immunological factors relating to the antitumor effect of temozolomide chemoimmunotherapy in a murine glioma model. Clin Vaccine Immunol (2009) 0.95
Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas. J Neurooncol (2006) 0.95
A personal consecutive series of surgically treated 51 cases of insular WHO Grade II glioma: advances and limitations. J Neurosurg (2009) 0.94
Immunological considerations of modern animal models of malignant primary brain tumors. J Transl Med (2009) 0.93
Cure of established GL261 mouse gliomas after combined immunotherapy with GM-CSF and IFNgamma is mediated by both CD8+ and CD4+ T-cells. Int J Cancer (2009) 0.92
Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex. J Inorg Biochem (2011) 0.90
Current and investigational drug strategies for glioblastoma. Clin Oncol (R Coll Radiol) (2014) 0.86
Structure-activity relationships and DNA binding properties of apoptosis inducing cytotoxic rhodium(III) polypyridyl complexes containing the cyclic thioether [9]aneS(3). J Inorg Biochem (2009) 0.86
Optimization of the route of platinum drugs administration to optimize the concomitant treatment with radiotherapy for glioblastoma implanted in the Fischer rat brain. J Neurooncol (2013) 0.84
In vivo antitumor activity of bis(4,7-dimethyl-1,10-phenanthroline) sulfatooxovanadium(IV) (METVAN [VO(SO4)(Me2-Phen)2]). Clin Cancer Res (2001) 0.84
DNA binding properties of novel cytotoxic gold(III) complexes of terpyridine ligands: the impact of steric and electrostatic effects. J Biol Inorg Chem (2006) 0.83
Stabilin-1 expression in tumor associated macrophages. Brain Res (2012) 0.81
Overcoming cisplatin resistance using gold(III) mimics: anticancer activity of novel gold(III) polypyridyl complexes. J Inorg Biochem (2011) 0.80
Cytotoxic rhodium(III) and iridium(III) polypyridyl complexes: structure-activity relationships, antileukemic activity, and apoptosis induction. ChemMedChem (2009) 0.77
Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands. J Inorg Biochem (2013) 0.76
Cytotoxicity and effects of 1,10-phenanthroline and 5-amino-1,10-phenanthroline derivatives on some immunocompetent cells. Eur J Med Chem (2009) 0.76
Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol (2006) 7.89
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med (2006) 3.36
Generalized Lévy walks and the role of chemokines in migration of effector CD8+ T cells. Nature (2012) 2.38
Chitinase dependent control of protozoan cyst burden in the brain. PLoS Pathog (2012) 1.68
Adsorption of frog foam nest proteins at the air-water interface. Biophys J (2004) 1.60
Dynamic Imaging of CD8(+) T cells and dendritic cells during infection with Toxoplasma gondii. PLoS Pathog (2009) 1.37
Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells. Infect Immun (2007) 1.26
Transcriptional changes underlying the secretory activation phase of mammary gland development. Mol Endocrinol (2005) 1.23
Kinetics and phenotype of vaccine-induced CD8+ T-cell responses to Toxoplasma gondii. Infect Immun (2009) 1.10
Virulence of Toxoplasma gondii is associated with distinct dendritic cell responses and reduced numbers of activated CD8+ T cells. J Immunol (2010) 1.07
β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway. Proc Natl Acad Sci U S A (2012) 1.03
Inaccuracies in MTS assays: major distorting effects of medium, serum albumin, and fatty acids. Biotechniques (2004) 1.02
CCR7-dependent immunity during acute Toxoplasma gondii infection. Infect Immun (2010) 1.00
CNS-derived CCL21 is both sufficient to drive homeostatic CD4+ T cell proliferation and necessary for efficient CD4+ T cell migration into the CNS parenchyma following Toxoplasma gondii infection. Brain Behav Immun (2010) 0.99
Selective cavitand-mediated endocytosis of targeted imaging agents into live cells. J Am Chem Soc (2013) 0.97
Monitoring anthrax toxin receptor dissociation from the protective antigen by NMR. Protein Sci (2009) 0.96
Unmodified prolactin (PRL) and S179D PRL-initiated bioluminescence resonance energy transfer between homo- and hetero-pairs of long and short human PRL receptors in living human cells. Mol Endocrinol (2005) 0.94
S179D prolactin increases vitamin D receptor and p21 through up-regulation of short 1b prolactin receptor in human prostate cancer cells. Cancer Res (2005) 0.92
Elevated prolactin redirects secretory vesicle traffic in rabbit lacrimal acinar cells. Am J Physiol Endocrinol Metab (2006) 0.91
Tumor cytotoxicity of 5,6-dimethyl-1,10-phenanthroline and its corresponding gold(III) complex. J Inorg Biochem (2011) 0.90
T-cell production of matrix metalloproteinases and inhibition of parasite clearance by TIMP-1 during chronic Toxoplasma infection in the brain. ASN Neuro (2011) 0.87
Prolactin increases survival and migration of ovarian cancer cells: importance of prolactin receptor type and therapeutic potential of S179D and G129R receptor antagonists. Cancer Lett (2011) 0.87
Prolactin blocks nuclear translocation of VDR by regulating its interaction with BRCA1 in osteosarcoma cells. Mol Endocrinol (2008) 0.86
S179D prolactin sensitizes human prostate cancer cells such that physiological concentrations of 1, 25 dihydroxy vitamin D3 result in growth inhibition and cell death. Prostate (2007) 0.85
Different biological effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin involve different signaling pathways. Biochemistry (2003) 0.85
Inhibition of prolactin (PRL)-induced proliferative signals in breast cancer cells by a molecular mimic of phosphorylated PRL, S179D-PRL. Endocrinology (2003) 0.85
12/15-lipoxygenase-dependent myeloid production of interleukin-12 is essential for resistance to chronic toxoplasmosis. Infect Immun (2009) 0.85
Effects of nanoencapsulation and PEGylation on biodistribution of indocyanine green in healthy mice: quantitative fluorescence imaging and analysis of organs. Int J Nanomedicine (2013) 0.85
Synthesis and characterization of gold(III) complexes possessing 2,9-dialkylphenanthroline ligands: to bind or not to bind? Dalton Trans (2009) 0.85
Trans-epithelial immune cell transfer during suckling modulates delayed-type hypersensitivity in recipients as a function of gender. PLoS One (2008) 0.85
Prolactin and estradiol utilize distinct mechanisms to increase serine-118 phosphorylation and decrease levels of estrogen receptor alpha in T47D breast cancer cells. Breast Cancer Res Treat (2009) 0.84
NF-kappaB1 contributes to T cell-mediated control of Toxoplasma gondii in the CNS. J Neuroimmunol (2010) 0.84
A molecular mimic demonstrates that phosphorylated human prolactin is a potent anti-angiogenic hormone. Endocr Relat Cancer (2006) 0.84
S179D prolactin primarily uses the extrinsic pathway and mitogen-activated protein kinase signaling to induce apoptosis in human endothelial cells. Endocrinology (2006) 0.84
Role of C-C chemokine receptor type 7 and its ligands during neuroinflammation. J Neuroinflammation (2012) 0.84
The rhythmic secretion of mating-induced prolactin secretion is controlled by prolactin acting centrally. Endocrinology (2009) 0.83
Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists. Mol Endocrinol (2005) 0.82
p21-activated protein kinase gamma-PAK in pituitary secretory granules phosphorylates prolactin. FEBS Lett (2002) 0.82
Different forms of prolactin have opposing effects on the expression of cell cycle regulatory proteins in differentiated mammary epithelial cells. Oncol Res (2006) 0.82
S2 deletion variants of human PRL receptors demonstrate that extracellular domain conformation can alter conformation of the intracellular signaling domain. Biochemistry (2007) 0.82
Stabilin-1 expression in tumor associated macrophages. Brain Res (2012) 0.81
The EphB4 receptor promotes the growth of melanoma cells expressing the ephrin-B2 ligand. Pigment Cell Melanoma Res (2010) 0.81
Paradigm-shifters: phosphorylated prolactin and short prolactin receptors. J Mammary Gland Biol Neoplasia (2008) 0.81
Human chorionic gonadotropin beta (HCGbeta) down-regulates E-cadherin and promotes human prostate carcinoma cell migration and invasion. Cancer (2006) 0.80
Short form 1b human prolactin receptor down-regulates expression of the long form. J Mol Endocrinol (2009) 0.80
Local cytokine levels associated with delayed-type hypersensitivity responses: modulation by gender, ovariectomy, and estrogen replacement. J Endocrinol (2007) 0.80
Opposite effects of unmodified prolactin and a molecular mimic of phosphorylated prolactin on morphology and the expression of prostate specific genes in the normal rat prostate. Prostate (2003) 0.79
Dark side illuminated: imaging of Toxoplasma gondii through the decades. Parasit Vectors (2013) 0.79
Pseudophosphorylated prolactin (S179D PRL) inhibits growth and promotes beta-casein gene expression in the rat mammary gland. Cell Tissue Res (2002) 0.79
Effects of prolactin on TSC2-null Eker rat cells and in pulmonary lymphangioleiomyomatosis. Am J Respir Crit Care Med (2010) 0.78
Characteristics and critical function of CD8+ T cells in the Toxoplasma-infected brain. Semin Immunopathol (2015) 0.78
A molecular mimic of phosphorylated prolactin (S179D PRL) secreted by eukaryotic cells has a conformation with an increased positive surface charge compared to that of unmodified prolactin. Biochemistry (2009) 0.77
Unmodified prolactin (PRL) promotes PRL secretion and acidophil hypertrophy and is associated with pituitary hyperplasia in female rats. Endocrine (2003) 0.77
Traffic of endogenous, transduced, and endocytosed prolactin in rabbit lacrimal acinar cells. Exp Eye Res (2007) 0.77
Antitumor properties of five-coordinate gold(III) complexes bearing substituted polypyridyl ligands. J Inorg Biochem (2013) 0.76
Maternal prolactin composition can permanently affect epidermal gammadeltaT cell function in the offspring. Dev Comp Immunol (2002) 0.76
Immunodominance and recognition of intracellular pathogens. J Infect Dis (2008) 0.76
Visualizing chemokine-dependent T cell activation and migration in response to central nervous system infection. Methods Mol Biol (2013) 0.75
S179D prolactin diminishes the effects of UV light on epidermal gamma delta T cells. Mol Cell Endocrinol (2007) 0.75
Structure and properties of neutral and cationic gold(III) complexes from substituted 2-(2'-pyridyl)quinoline ligands. Inorg Chem (2014) 0.75
Common and specific effects of the two major forms of prolactin in the rat testis. Am J Physiol Endocrinol Metab (2007) 0.75
Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. Cell Tissue Res (2011) 0.75
A major prolactin-binding complex on human milk fat globule membranes contains cyclophilins A and B: the complex is not the prolactin receptor. Am J Physiol Endocrinol Metab (2011) 0.75
Unexpected effects of UVB in IL-10 transgenic mice: normalization of contact hypersensitivity response. Arch Dermatol Res (2006) 0.75